Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FDA Approval

YONSA

CompanyCatalent Pharma Solutions, LLC (DUNS: 825745131)

Effective Date

November 16, 2023

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Abiraterone(125 mg in 1 1)

Manufacturing Establishments (2)

Sterling Chemical Malta Ltd

Labeler

Catalent Pharma Solutions, LLC

DUNS Number

360251875

Catalent Greenville, Inc.

Labeler

Catalent Pharma Solutions, LLC

DUNS Number

118812386

Products (1)

YONSA

NDC Product Code

11014-0566

Route of Administration

ORAL

Effective Date

November 16, 2023

Ingredients

AbirateroneActive

Code: EM5OCB9YJ6Class: ACTIBQuantity: 125 mg in 1 1

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy